Direkt zum Inhalt

Gruber, Isabella ; Edinger, Matthias ; Poeck, Hendrik ; Meedt, Elisabeth ; Holler, Ernst ; Herr, Wolfgang ; Koelbl, Oliver ; Wolff, Daniel ; Weber, Daniela

Early Broad-Spectrum Antibiotic Exposure is Associated with Increased Relapse after Myeloablative Total Body Irradiation-Based Allogeneic Hematopoietic Cell Transplantation

Artikel

Gruber, Isabella , Edinger, Matthias , Poeck, Hendrik , Meedt, Elisabeth, Holler, Ernst , Herr, Wolfgang, Koelbl, Oliver, Wolff, Daniel und Weber, Daniela (2026) Early Broad-Spectrum Antibiotic Exposure is Associated with Increased Relapse after Myeloablative Total Body Irradiation-Based Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy.

DOI zum Zitieren dieses Dokuments: 10.5283/epub.81160


Zusammenfassung

Background Broad-spectrum antibiotics are frequently administered during the peri-transplant period in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Antibiotic exposure can disrupt the intestinal microbiota and may influence immune recovery and post-transplant outcomes. However, the association between the timing of therapeutic antibiotic exposure relative to stem ...

Background
Broad-spectrum antibiotics are frequently administered during the peri-transplant period in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Antibiotic exposure can disrupt the intestinal microbiota and may influence immune recovery and post-transplant outcomes. However, the association between the timing of therapeutic antibiotic exposure relative to stem cell infusion and relapse after myeloablative total body irradiation (TBI)-based conditioning remains poorly defined.
Objectives
To investigate whether the timing of therapeutic antibiotic exposure relative to stem cell infusion is associated with relapse and other transplantation outcomes in adults undergoing myeloablative TBI-based allo-HCT.
Study Design
We retrospectively analyzed 160 adults with acute myeloid leukemia (n = 59) or acute lymphoblastic leukemia (n = 101) undergoing first allo-HCT following myeloablative TBI (8 or 12 Gy). Therapeutic antibiotic exposure was classified as early (initiation before stem cell infusion on Day 0; observed range, Day −20 to −1) or non-early (initiation on Day 0 or thereafter during the initial hospitalization for allo-HCT, or no systemic therapeutic antibiotic exposure during this hospitalization). Primary endpoints were cumulative incidence of relapse (CIR) and nonrelapse mortality (NRM). Associations were evaluated using multivariable models adjusted for disease status, age, diagnosis, and TBI dose. Fine–Gray regression was used for relapse and NRM, and Cox regression for overall survival (OS) and progression-free survival (PFS). Sensitivity analyses included adjustment for calendar year, antithymocyte globulin (ATG) use, gut decontamination strategy, and institutional antibiotic protocol era. Landmark analyses were performed at Days +30 and +60, and interactions between early antibiotic exposure and clinically relevant factors were assessed.
Results
Median follow-up was 9.8 yr. Forty-five patients (28.1%) received early and 115 (71.9%) non-early therapeutic antibiotics. Baseline characteristics were broadly comparable between groups. Early antibiotic exposure was associated with a higher unadjusted CIR than non-early exposure (1-yr: 40% versus 17%; 2-yr: 45% versus 23%; Gray’s test P = .006), whereas unadjusted NRM was similar (2-yr: 16% versus 15%; Gray’s test P = .690). In multivariable Fine–Gray analyses, early antibiotic exposure was associated with a higher subdistribution hazard of relapse (SDHR 2.00, 95% confidence intervals [CI], 1.16 to 3.43; P = .013), but not with NRM or graft-versus-host disease (GVHD). No statistically significant interactions between early antibiotic exposure and disease status, diagnosis, age, or TBI dose were observed. Cause-specific Cox regression confirmed the association between early antibiotic exposure and relapse (CSHR 2.06, 95% CI, 1.20 to 3.56; P = .009). The association remained consistent after adjustment for calendar year, gut decontamination strategy, ATG use, and the institutional antibiotic protocol era, and in landmark analyses at Days +30 and +60. Early antibiotic exposure was associated with inferior OS (hazard ratios [HR] 1.66, 95% CI, 1.05 to 2.62; P = .030) and PFS (HR 1.75, 95% CI, 1.12 to 2.75; P = .014).
Conclusions
In adults with acute leukemia undergoing myeloablative TBI-based allo-HCT, early therapeutic antibiotic exposure was associated with increased relapse incidence and inferior survival, without detectable associations with GVHD or NRM. These observational findings support an association between antibiotic timing and leukemia control but do not establish causality or justify withholding clinically indicated antibiotic therapy. Prospective studies integrating detailed antibiotic exposure data, immune reconstitution analyses, and microbiome profiling are needed to determine whether antibiotic timing contributes to post-transplant relapse risk.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftTransplantation and Cellular Therapy
VerlagElsevier
Open Access ArtDEAL (Elsevier)
Datum21 September 2026
Veröffentlichungsdatum17 Nov 2026 05:42
InstitutionenMedizin > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medizin > Lehrstuhl für Strahlentherapie
Leibniz-Institut für Immuntherapie (LIT)
Identifikationsnummer
WertTyp
10.1016/j.jtct.2026.09.037DOI
Stichwörter / KeywordsAllogeneic hematopoietic cell transplantation, Total body irradiation, Acute leukemia, Broad-spectrum antibiotics, Relapse incidence, Nonrelapse mortality
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-811602
Dokumenten-ID81160

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben